23 results
8-K
EX-99.2
OPTN
OptiNose Inc
25 Apr 24
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
7:41am
administration Key Opinion Leader engagement Speaker’s Bureau Presentations at Medical Congresses Continuing Medical Education New Publications Disease
8-K
EX-10.1
OPTN
OptiNose Inc
13 Jun 23
Departure of Directors or Certain Officers
4:35pm
”) hereby engages you, Joseph C. Scodari (“you” or “Consultant”) as a consultant to the Company. By signing this letter, you accept this engagement … , or to participate in any benefit plans of the Company while engaged as a Consultant.
4. Independent Consultant. Consultant’s engagement hereunder
8-K
EX-10.1
OPTN
OptiNose Inc
16 Dec 22
Departure of Directors or Certain Officers
4:43pm
” or “Consultant”), as a consultant to the Company. By signing this letter, Provider accepts this engagement subject to these terms and conditions.
1 … Consulting Fee for the remainder of the engagement.
3.Compensation.
(a)Consulting Fee. The Company shall pay to Consultant the consulting fee
8-K/A
EX-99.1
uhjn5
27 Sep 22
Departure of Directors or Certain Officers
4:38pm
10-K
EX-10.1
sg1ixne6thgnjxt2m 2s
13 Mar 18
Annual report
12:00am
10-K
5w10fpl
13 Mar 18
Annual report
12:00am